DE60329500D1 - Verfahren zur identifikation von salzempfindlichen personen - Google Patents

Verfahren zur identifikation von salzempfindlichen personen

Info

Publication number
DE60329500D1
DE60329500D1 DE60329500T DE60329500T DE60329500D1 DE 60329500 D1 DE60329500 D1 DE 60329500D1 DE 60329500 T DE60329500 T DE 60329500T DE 60329500 T DE60329500 T DE 60329500T DE 60329500 D1 DE60329500 D1 DE 60329500D1
Authority
DE
Germany
Prior art keywords
salt
binding activity
sensitive persons
sensitivity
identifying salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60329500T
Other languages
English (en)
Inventor
Myrtle Thierry-Palmer
Mohamed Bayorh
Akins Doherty
Keri Griffin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morehouse School of Medicine Inc
Original Assignee
Morehouse School of Medicine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morehouse School of Medicine Inc filed Critical Morehouse School of Medicine Inc
Application granted granted Critical
Publication of DE60329500D1 publication Critical patent/DE60329500D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/534—Production of labelled immunochemicals with radioactive label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/321—Arterial hypertension

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Seasonings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60329500T 2002-07-12 2003-07-11 Verfahren zur identifikation von salzempfindlichen personen Expired - Lifetime DE60329500D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39545702P 2002-07-12 2002-07-12
PCT/US2003/021843 WO2004006844A2 (en) 2002-07-12 2003-07-11 Method for identifying salt-sensitive persons

Publications (1)

Publication Number Publication Date
DE60329500D1 true DE60329500D1 (de) 2009-11-12

Family

ID=30115875

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60329500T Expired - Lifetime DE60329500D1 (de) 2002-07-12 2003-07-11 Verfahren zur identifikation von salzempfindlichen personen

Country Status (6)

Country Link
US (1) US7888000B2 (de)
EP (1) EP1534075B1 (de)
AT (1) ATE444493T1 (de)
AU (1) AU2003256515A1 (de)
DE (1) DE60329500D1 (de)
WO (1) WO2004006844A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2633325B1 (de) * 2010-10-29 2016-12-28 Cohesive Technologies Inc. Lc-ms-trennung und detektion von vitamin-d-metaboliten
EP2633324B1 (de) 2010-10-29 2018-11-21 Cohesive Technologies Inc. Lc-ms-konfiguration für die reinigung und den nachweis von analyten mit verschiedensten hydrophoben eigenschaften

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3772150A (en) * 1971-12-29 1973-11-13 Us Health Process for producing vitamin d{11 {11 metabolite
US4269777A (en) * 1979-05-21 1981-05-26 Wisconsin Alumni Research Foundation Isotopically labeled vitamin D derivatives and processes for preparing same
US4229359A (en) * 1979-09-04 1980-10-21 Wisconsin Alumni Research Foundation Derivatives of 25-hydroxycholecalciferol
US4883791A (en) * 1987-09-21 1989-11-28 Board Of Regents, The University Of Texas System 25S,26-dihydroxycholecalciferol in the treatment of hypercalcitriolemic disease states
US5202266A (en) * 1987-10-14 1993-04-13 Asahi Kasei Kogyo Kabushiki Kaisha 25-hydroxy vitamin D3 derivatives, process for their production, and assay method using the same
JP3152933B2 (ja) * 1993-05-17 2001-04-03 アマーシャム・インターナショナル・ピーエルシー 細胞生化学プロセスを測定するための装置および方法
GB9317193D0 (en) * 1993-08-18 1993-10-06 Zeneca Ltd Method
US6010861A (en) * 1994-08-03 2000-01-04 Dgi Biotechnologies, Llc Target specific screens and their use for discovering small organic molecular pharmacophores
US5695794A (en) * 1995-08-10 1997-12-09 Amoco Corporation Use of 25-hydroxycholecalciferol in a dietary supplement process for ameliorating the effects of tibial dyschondroplasia in poultry while maintaining weight gain
DE19981132D2 (de) * 1998-06-25 2001-10-18 Immundiagnostik Ges Fuer Produ Funktionelle Vitamin-D-Derivate und Verfahren zur Bestimmung von 25-Hydroxy- und 1alpha,25-Dihydroxy-Vitamin-D
US6610504B1 (en) * 2000-04-10 2003-08-26 General Atomics Methods of determining SAM-dependent methyltransferase activity using a mutant SAH hydrolase
GB0029729D0 (en) 2000-12-06 2001-01-17 Ids Ltd Method for detection of vitamin D metabolites
US7087395B1 (en) * 2001-01-16 2006-08-08 Quest Diagnostics Investments Incorporated Vitamin D assay

Also Published As

Publication number Publication date
ATE444493T1 (de) 2009-10-15
EP1534075A4 (de) 2007-05-09
EP1534075B1 (de) 2009-09-30
US7888000B2 (en) 2011-02-15
AU2003256515A1 (en) 2004-02-02
WO2004006844A3 (en) 2004-06-24
AU2003256515A8 (en) 2004-02-02
US20040072374A1 (en) 2004-04-15
WO2004006844A2 (en) 2004-01-22
EP1534075A2 (de) 2005-06-01

Similar Documents

Publication Publication Date Title
DE60320101D1 (de) Verfahren für regressionsanalyse von formationsparametern
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
ATE460668T1 (de) Verfahren zur prognose von brustkrebs mittels quantifizierung von zellulären folat vitamin rezeptoren
DE60040677D1 (de) Verbessertes toxizität-screening verfahren
AU2003278768A1 (en) Method and system for assessment of biomarkers by measurement of response to stimulus
ATE482398T1 (de) Verfahren zur stratifizierung von herzinsuffizienz
ATE495243T1 (de) Verfahren zur herstellung von hochempfindlichen endonukleasen, neuartige zubereitungen von nukleasen und ihre verwendung
ATE514950T1 (de) Verfahren zur untersuchung von sepsis bei menschen
NO20031624D0 (no) Galvanisk metode for måling av elektrisk anisotropi
ATE336597T1 (de) Verfahren zur gewinnung von gold
DE60229303D1 (de) Bioäquivalenztest für eisenhaltige formulierungen
ATE414701T1 (de) Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren
WO2003076896A3 (en) Use of biomarkers to detect breast cancer
WO2005012901A3 (en) Method for measuring aromatase activity
DE60301283D1 (de) Verfahren zur Bestimmung von Biopolymeren
ATE444493T1 (de) Verfahren zur identifikation von salzempfindlichen personen
ATE412182T1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
DE602007004570D1 (de) Verwendung von Nogo-C bei der Beurteilung von Herzversagen
MXPA04004018A (es) Metodos de separacion por exclusion para toxicidad de compuestos de prueba.
ATE449380T1 (de) System und verfahren zur quantitativen anwendungsmessung
ATE519860T1 (de) Verwendung von ribozymen zur detektion ebenfalls vorhandener agenzien
DE50312755D1 (de) Verfahren zur Bestimmung des Verschleisses eines elektrochemischen Energiespeichers
FR2842305B1 (fr) Procede de determination de l'independance d'un systeme electrochimique
MX2007002477A (es) Marcador polipeptidico para el diagnostico de arteriosclerosis.
DE60324348D1 (de) Verfahren zur Beurteilung der Empfindlichkeit der Haut

Legal Events

Date Code Title Description
8364 No opposition during term of opposition